Qian-sheng Yu

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

Nigel H. Greig, Tadanobu Utsuki, Donald K. Ingram et al. · Proceedings of the National Academy of Sciences · 2005 · 708 citations · Full text

Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice

Yoko Furukawa‐Hibi, Tursun Alkam, Atsumi Nitta et al. · Behavioural Brain Research · 2011 · 141 citations · Full text

Neurodegenerative Diseases, Butyrylcholinesterase Inhibitors, Cognitive Dysfunction +8

The Experimental Alzheimer’s Disease Drug Posiphen [(+)-Phenserine] Lowers Amyloid-β Peptide Levels in Cell Culture and Mice

Debomoy K. Lahiri, DeMao Chen, Bryan Maloney et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 131 citations

Novel p53 Inactivators with Neuroprotective Action:  Syntheses and Pharmacological Evaluation of 2-Imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-Imino-2,3,4,5,6,7-hexahydrobenzoxazole Derivatives

Xiaoxiang Zhu, Qian-sheng Yu, Roy G. Cutler et al. · Journal of Medicinal Chemistry · 2002 · 106 citations

Apoptosis, Novel Analogues, Cell Death +17

Thiothalidomides:  Novel Isosteric Analogues of Thalidomide with Enhanced TNF-α Inhibitory Activity

Xiaoxiang Zhu, Tony Giordano, Qian-sheng Yu et al. · Journal of Medicinal Chemistry · 2003 · 82 citations

Pharmaceutical Science, Chemoprevention Strategy, Immunology +18